Scientific Sessions 2024  /  Translating 'Almost' 100 Years of Lipoprotein Research: Current and Future Lipoprotein Interventions - Its All in the Mechanism  /  Targeting triglyceride-rich lipoproteins: Beyond fibrates and fish oils
Logo

American Heart Association

  113
  0

Final ID:

Targeting triglyceride-rich lipoproteins: Beyond fibrates and fish oils

  • Cariou, Bertrand  ( CHU Nantes , Nantes Cedex 1 , France )
  • Hobbs, Helen  ( HHMI-UT SOUTHWESTERN , Dallas , Texas , United States )
  • Boren, Jan  ( University of Gothenburg , Gothenburg , Sweden )
    • Author Disclosures:
    Bertrand Cariou: DO have relevant financial relationships ; Advisor:Novartis:Active (exists now) ; Advisor:Ultragenyx:Past (completed) ; Speaker:Amgen:Past (completed) ; Advisor:MSD:Active (exists now) ; Advisor:Eli Lilly:Active (exists now) ; Advisor:Novo-Nordisk:Active (exists now) ; Speaker:Astra-Zeneca:Past (completed) ; Speaker:Sanofi:Active (exists now) ; Research Funding (PI or named investigator):Sanofi:Past (completed) | Helen Hobbs: DO NOT have relevant financial relationships | Jan Boren: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Translating 'Almost' 100 Years of Lipoprotein Research: Current and Future Lipoprotein Interventions - Its All in the Mechanism

Sunday, 11/17/2024 , 03:30PM - 04:45PM

Cardiovascular Seminar

More abstracts on this topic:
The future of HDL modifying therapies

Davidson William, Marsche Gunther

Genetic and non-genetic influences on Lp(a) levels

Byambaa Enkhmaa, Kamstrup Pia

More abstracts from these authors:
New Frontiers in Triglyceride Lowering

Tokgozoglu Lale, Remaley Alan T, Cariou Bertrand, Hudgins Lisa

Long-term Efficacy and Safety of Lerodalcibep in the Open-label 72-week Extension Study of Subjects Previously on Inclisiran or Lerodalcibep in the LIBerate-VI Trial

Asprusten Emil, Licka Manuela, Cariou Bertrand, Vest Jeff, Kallend David, Stein Evan

You have to be authorized to contact abstract author. Please, Login
Not Available